Cargando…
106: REVIEW OF SCREENING PROGRAM EFFECT ON INCIDENCE OF HEMOLYTIC DISEASE DUE TO G6PD DEFICIENCIES
BACKGROUND AND AIMS: G6PD deficiencies is a genetically issue that is noticed and is wide spread in our region and around the world. Despite the screening program for this disease since 2005 there are noticeable cases. METHODS: In this descriptive study the file of 923 patients that were diagnosed w...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759429/ http://dx.doi.org/10.1136/bmjopen-2016-015415.106 |
_version_ | 1783291196704030720 |
---|---|
author | Tarhani, Fariba Dalvand, Shabnam |
author_facet | Tarhani, Fariba Dalvand, Shabnam |
author_sort | Tarhani, Fariba |
collection | PubMed |
description | BACKGROUND AND AIMS: G6PD deficiencies is a genetically issue that is noticed and is wide spread in our region and around the world. Despite the screening program for this disease since 2005 there are noticeable cases. METHODS: In this descriptive study the file of 923 patients that were diagnosed with Favism and hospitalized in Khorramabad hospitals during 2005 and 2015 were reviewed. This information includes the number of occurrence for each year, the causes of new cases which analyzed and recorded. CONCLUSION: Even so the cases reduced from 102 at 2005 to 33 at 2015 (60% reduction) but the most case were on 2009 and 2013 with 102 case and 145 case respectively. The cause of developing of these case is under observation and consideration. The most noticeable causes of occurrences are misunderstanding of the parents from permanent nature of disease (63.0%), neglecting disease (12.0%), Lack of providing of screening results to parents (12.0%) and use of Oxidant agents without parental supervision (8.0%), use of wrong Oxidant medication (5.0%). Despite of large expenses for screening program it seems that educate and providing information to the parents needs revision. |
format | Online Article Text |
id | pubmed-5759429 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-57594292018-02-12 106: REVIEW OF SCREENING PROGRAM EFFECT ON INCIDENCE OF HEMOLYTIC DISEASE DUE TO G6PD DEFICIENCIES Tarhani, Fariba Dalvand, Shabnam BMJ Open Abstracts from the 5th International Society for Evidence-Based Healthcare Congress, Kish Island, Ira BACKGROUND AND AIMS: G6PD deficiencies is a genetically issue that is noticed and is wide spread in our region and around the world. Despite the screening program for this disease since 2005 there are noticeable cases. METHODS: In this descriptive study the file of 923 patients that were diagnosed with Favism and hospitalized in Khorramabad hospitals during 2005 and 2015 were reviewed. This information includes the number of occurrence for each year, the causes of new cases which analyzed and recorded. CONCLUSION: Even so the cases reduced from 102 at 2005 to 33 at 2015 (60% reduction) but the most case were on 2009 and 2013 with 102 case and 145 case respectively. The cause of developing of these case is under observation and consideration. The most noticeable causes of occurrences are misunderstanding of the parents from permanent nature of disease (63.0%), neglecting disease (12.0%), Lack of providing of screening results to parents (12.0%) and use of Oxidant agents without parental supervision (8.0%), use of wrong Oxidant medication (5.0%). Despite of large expenses for screening program it seems that educate and providing information to the parents needs revision. BMJ Publishing Group 2017-02-08 /pmc/articles/PMC5759429/ http://dx.doi.org/10.1136/bmjopen-2016-015415.106 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
spellingShingle | Abstracts from the 5th International Society for Evidence-Based Healthcare Congress, Kish Island, Ira Tarhani, Fariba Dalvand, Shabnam 106: REVIEW OF SCREENING PROGRAM EFFECT ON INCIDENCE OF HEMOLYTIC DISEASE DUE TO G6PD DEFICIENCIES |
title | 106: REVIEW OF SCREENING PROGRAM EFFECT ON INCIDENCE OF HEMOLYTIC DISEASE DUE TO G6PD DEFICIENCIES |
title_full | 106: REVIEW OF SCREENING PROGRAM EFFECT ON INCIDENCE OF HEMOLYTIC DISEASE DUE TO G6PD DEFICIENCIES |
title_fullStr | 106: REVIEW OF SCREENING PROGRAM EFFECT ON INCIDENCE OF HEMOLYTIC DISEASE DUE TO G6PD DEFICIENCIES |
title_full_unstemmed | 106: REVIEW OF SCREENING PROGRAM EFFECT ON INCIDENCE OF HEMOLYTIC DISEASE DUE TO G6PD DEFICIENCIES |
title_short | 106: REVIEW OF SCREENING PROGRAM EFFECT ON INCIDENCE OF HEMOLYTIC DISEASE DUE TO G6PD DEFICIENCIES |
title_sort | 106: review of screening program effect on incidence of hemolytic disease due to g6pd deficiencies |
topic | Abstracts from the 5th International Society for Evidence-Based Healthcare Congress, Kish Island, Ira |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759429/ http://dx.doi.org/10.1136/bmjopen-2016-015415.106 |
work_keys_str_mv | AT tarhanifariba 106reviewofscreeningprogrameffectonincidenceofhemolyticdiseaseduetog6pddeficiencies AT dalvandshabnam 106reviewofscreeningprogrameffectonincidenceofhemolyticdiseaseduetog6pddeficiencies |